Live
- All set for Polycet-2024 tomorrow
- Dr Srinivas gets best veterinary surgeon award
- Hyderabad: Jobs top debutant voters’ wish list
- Devotees rush increases at Tirumala today, to take 8 hours for sarva darshans
- Sajjala denounces Naidu’s ‘heinous politics’
- NDA parties release ‘charge sheet’ against Jagan
- Actor Nikhil Siddharth roots for TDP, takes part in campaign
- Hyderabad: Religious jingoism will not fill empty stomachs says K Chandrashekar Rao
- Hyderabad: BJP does not spare even Gods says Revanth Reddy
- Hyderabad: Will end 4% quota for Muslims in TS says Amit Shah
Why medication fails to address mood disorders
Highlights
The majority of people with mood and anxiety disorders who receive the most commonly prescribed anti-depressants -- called SSRIs -- are not helped by these medications. A new research sheds light on why Selective Serotonin Reuptake Inhibitors or SSRIs fail to work in most patients. SSRIs are designed to increase serotonin, a neurotransmitter in the brain that is key to maintenance of mood.
New York: The majority of people with mood and anxiety disorders who receive the most commonly prescribed anti-depressants -- called SSRIs -- are not helped by these medications. A new research sheds light on why Selective Serotonin Reuptake Inhibitors or SSRIs fail to work in most patients. SSRIs are designed to increase serotonin, a neurotransmitter in the brain that is key to maintenance of mood.
The researchers advocate that additional studies should be performed as better understanding of the serotonin system will significantly improve future treatment options. Coplan noted that a recent large-scale study showed only a minority of patients do well on SSRIs, and of those, many lose response in a year or two.
Next Story
ADVERTISEMENT
